BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 28253222)

  • 1. Phenotyping of myocardial fibrosis in hypertensive patients with heart failure. Influence on clinical outcome.
    Ravassa S; López B; Querejeta R; Echegaray K; San José G; Moreno MU; Beaumont FJ; González A; Díez J
    J Hypertens; 2017 Apr; 35(4):853-861. PubMed ID: 28253222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial Collagen Cross-Linking Is Associated With Heart Failure Hospitalization in Patients With Hypertensive Heart Failure.
    López B; Ravassa S; González A; Zubillaga E; Bonavila C; Bergés M; Echegaray K; Beaumont J; Moreno MU; San José G; Larman M; Querejeta R; Díez J
    J Am Coll Cardiol; 2016 Jan; 67(3):251-60. PubMed ID: 26796388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarker-based phenotyping of myocardial fibrosis identifies patients with heart failure with preserved ejection fraction resistant to the beneficial effects of spironolactone: results from the Aldo-DHF trial.
    Ravassa S; Trippel T; Bach D; Bachran D; González A; López B; Wachter R; Hasenfuss G; Delles C; Dominiczak AF; Pieske B; Díez J; Edelmann F
    Eur J Heart Fail; 2018 Sep; 20(9):1290-1299. PubMed ID: 29709099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of Circulating Type I Collagen-Related Biomarkers Is Associated With Atrial Fibrillation.
    Ravassa S; Ballesteros G; López B; Ramos P; Bragard J; González A; Moreno MU; Querejeta R; Vives E; García-Bolao I; Díez J
    J Am Coll Cardiol; 2019 Apr; 73(12):1398-1410. PubMed ID: 30922470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galectin-3 and histological, molecular and biochemical aspects of myocardial fibrosis in heart failure of hypertensive origin.
    López B; González A; Querejeta R; Zubillaga E; Larman M; Díez J
    Eur J Heart Fail; 2015 Apr; 17(4):385-92. PubMed ID: 25684565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Procollagen type I carboxy-terminal propeptide (PICP) and MMP-2 are potential biomarkers of myocardial fibrosis in patients with hypertrophic cardiomyopathy.
    Yang C; Qiao S; Song Y; Liu Y; Tang Y; Deng L; Yuan J; Hu F; Yang W
    Cardiovasc Pathol; 2019; 43():107150. PubMed ID: 31639652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of cystatin C with heart failure with preserved ejection fraction in elderly hypertensive patients: potential role of altered collagen metabolism.
    Huerta A; López B; Ravassa S; San José G; Querejeta R; Beloqui Ó; Zubillaga E; Rábago G; Brugnolaro C; Díez J; González A
    J Hypertens; 2016 Jan; 34(1):130-8. PubMed ID: 26575701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of Collagen Carboxy-Terminal Propeptide and Telopeptide to Predict Disturbances of Long-Term Mortality in Patients ≥60 Years With Heart Failure and Reduced Ejection Fraction.
    Löfsjögård J; Kahan T; Díez J; López B; González A; Ravassa S; Mejhert M; Edner M; Persson H
    Am J Cardiol; 2017 Jun; 119(12):2042-2048. PubMed ID: 28464988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating collagen metabolites, myocardial fibrosis and heart failure in aortic valve stenosis.
    Kupari M; Laine M; Turto H; Lommi J; Werkkala K
    J Heart Valve Dis; 2013 Mar; 22(2):166-76. PubMed ID: 23798204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers of collagen type I metabolism are related to B-type natriuretic peptide, left ventricular size, and diastolic function in heart failure.
    Löfsjögård J; Kahan T; Díez J; López B; González A; Edner M; Henriksson P; Mejhert M; Persson H
    J Cardiovasc Med (Hagerstown); 2014 Jun; 15(6):463-9. PubMed ID: 24983265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased collagen type I synthesis in patients with heart failure of hypertensive origin: relation to myocardial fibrosis.
    Querejeta R; López B; González A; Sánchez E; Larman M; Martínez Ubago JL; Díez J
    Circulation; 2004 Sep; 110(10):1263-8. PubMed ID: 15313958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of circulating markers of fibrosis and progression of left and right ventricular dysfunction in hypertensive patients with heart failure.
    Plaksej R; Kosmala W; Frantz S; Herrmann S; Niemann M; Störk S; Wachter R; Angermann CE; Ertl G; Bijnens B; Weidemann F
    J Hypertens; 2009 Dec; 27(12):2483-91. PubMed ID: 19887955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diastolic heart failure: evidence of increased myocardial collagen turnover linked to diastolic dysfunction.
    Martos R; Baugh J; Ledwidge M; O'Loughlin C; Conlon C; Patle A; Donnelly SC; McDonald K
    Circulation; 2007 Feb; 115(7):888-95. PubMed ID: 17283265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial fibrillation and biomarkers of myocardial fibrosis in heart failure.
    Löfsjögård J; Persson H; Díez J; López B; González A; Edner M; Mejhert M; Kahan T
    Scand Cardiovasc J; 2014 Oct; 48(5):299-303. PubMed ID: 24978653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Left ventricular mass, diastolic function and collagen metabolism biomarkers in essential hypertension].
    Macías Blanco C; Fatela-Cantillo D; Jiménez-Jiménez L; López Aguilar R; Moreno-Luna R; Doblas Delgado A; Stiefel P
    Med Clin (Barc); 2012 Feb; 138(4):139-44. PubMed ID: 21939991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Independent and additive prognostic ability of serum carboxy-terminal telopeptide of collagen type-I in heart failure patients: a multi-marker approach with high-negative predictive value to rule out long-term adverse events.
    Tziakas DN; Chalikias GK; Stakos D; Chatzikyriakou SV; Papazoglou D; Mitrousi K; Lantzouraki A; Thomaidi A; Boudoulas H; Konstantinides S
    Eur J Prev Cardiol; 2012 Feb; 19(1):62-71. PubMed ID: 20479644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of prolonged-release torasemide versus furosemide on myocardial fibrosis in hypertensive patients with chronic heart failure: a randomized, blinded-end point, active-controlled study.
    TORAFIC Investigators Group
    Clin Ther; 2011 Sep; 33(9):1204-1213.e3. PubMed ID: 21906812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum carboxy-terminal propeptide of procollagen type I is a marker of myocardial fibrosis in hypertensive heart disease.
    Querejeta R; Varo N; López B; Larman M; Artiñano E; Etayo JC; Martínez Ubago JL; Gutierrez-Stampa M; Emparanza JI; Gil MJ; Monreal I; Mindán JP; Díez J
    Circulation; 2000 Apr; 101(14):1729-35. PubMed ID: 10758057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of myocardial fibrosis by late gadolinium enhancement imaging and biomarkers of collagen metabolism in chronic rheumatic mitral regurgitation.
    Meel R; Nethononda R; Libhaber E; Dix-Peek T; Peters F; Essop M
    Cardiovasc J Afr; 2018 May/Jun 23; 29(3):150-154. PubMed ID: 29443354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical assessment of myocardial fibrosis in hypertensive heart disease.
    López B; González A; Varo N; Laviades C; Querejeta R; Díez J
    Hypertension; 2001 Nov; 38(5):1222-6. PubMed ID: 11711527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.